- Home
- ETON vs UDMY Comparison
ETON vs UDMY Comparison
Compare ETON & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | UDMY |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.7M | 716.5M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ETON | UDMY |
|---|---|---|
| Price | $28.79 | $4.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $39.33 | $9.29 |
| AVG Volume (30 Days) | 380.3K | ★ 1.3M |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 105.36 |
| EPS | ★ 0.05 | N/A |
| Revenue | $79,950,000.00 | ★ $789,844,000.00 |
| Revenue This Year | $40.90 | $4.12 |
| Revenue Next Year | $47.23 | $4.54 |
| P/E Ratio | $552.20 | ★ N/A |
| Revenue Growth | ★ 104.94 | 0.42 |
| 52 Week Low | $13.09 | $4.02 |
| 52 Week High | $35.66 | $8.09 |
Technical Indicators
Market Signals| Indicator | ETON | UDMY |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 47.24 |
| Support Level | $28.00 | $4.23 |
| Resistance Level | $32.31 | $5.20 |
| Average True Range (ATR) | 2.00 | 0.30 |
| MACD | -0.78 | -0.01 |
| Stochastic Oscillator | 22.89 | 46.77 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Enterprise segment and Consumer segment, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America, and also has its presence in Europe, Middle East, Africa; Asia Pacific; and Latin America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.